Metabolic dysfunction-associated steatotic liver disease (masld)
Clinical trials for Metabolic dysfunction-associated steatotic liver disease (masld) explained in plain language.
Never miss a new study
Get alerted when new Metabolic dysfunction-associated steatotic liver disease (masld) trials appear
Sign up with your email to follow new studies for Metabolic dysfunction-associated steatotic liver disease (masld), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Navy beans take on fatty liver: a diet swap put to the test
Disease control Not yet recruitingThis trial tests whether replacing some of the usual diet with navy beans — without changing total calories — is a practical and acceptable way to help manage metabolic dysfunction-associated steatotic liver disease (MASLD) in adults with intermediate-stage liver fibrosis. Forty …
Matched conditions: METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
DASH diet shows promise against childhood fatty liver
Disease control Not yet recruitingThis study tests whether the DASH diet (a heart-healthy eating plan) can improve liver health in 88 children aged 11–18 with MASLD, a common fatty liver condition linked to obesity. Participants will follow the DASH diet for 12 weeks, and researchers will measure changes in liver…
Matched conditions: METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)
Sponsor: Antalya Training and Research Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Natural compound SAMe tested to block liver cancer in High-Risk patients
Prevention Not yet recruitingThis study tests whether a natural supplement called SAMe can help prevent liver cancer in people with advanced fatty liver disease (MASLD) and cirrhosis. About 94 adults will receive either SAMe or a placebo for 12 months. Researchers will measure changes in a blood test that pr…
Matched conditions: METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)
Phase 2 • Sponsor: Cedars-Sinai Medical Center • Aim: Prevention
Last updated Jun 27, 2026 12:02 UTC
-
Can big data unmask hidden clusters of cardiometabolic disease?
Knowledge-focused Not yet recruitingThis study looks at anonymized health records from about 100,000 people in a Turkish hospital network to see how common cardiometabolic conditions—like obesity, type 2 diabetes, heart disease, fatty liver, and kidney disease—are and how often they occur together. By tracking thes…
Matched conditions: METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)
Sponsor: Novo Nordisk A/S • Aim: Knowledge-focused
Last updated Aug 26, 2026 00:00 UTC